Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts
Clinical Report

References

• Antinori A, Giancola M L, et al, 2003. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS. 16: 1867–1876
   Google Scholar
• Brew B J. 2001; AIDS dementia complex in HIV neurology. Oxford, Oxford University Press. pp. 53–90
   Google Scholar
• Brew B J. 2004. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS. 18: S75–S78. [PUBMED], [INFOTRIEVE]
   Web of Science ®Google Scholar
• Brew B J, Brown S J, et al, 1998; Safety and efficacy of Abacavir (ABC, 1952) in AIDS dementia complex (Study CNAB 3001), 12th World AIDS Conference. Geneva, 28 June–3 July.
   Google Scholar
• Brew B J, Pemberton L, et al, 1997. Levels of human Immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis. 175: 963–966. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Butters N, Grant I, et al, 1990. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workgroup on neuropsychological assessment approaches. J Clin Exp Neuropsychol. 12: 963–978. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Crowe S, Benedict T, et al, 1999. Cognitive determinants of performance on the Digit Symbol-coding test, the Symbol Search Test of the WAIS-III, and the Symbol Digit Modalities Test: an analysis in a healthy sample. Aust Psychol. 34: 204–210
   Web of Science ®Google Scholar
• Cunningham P, Smith D, et al, 2000. Evidence for independent development of reverse transcriptase inhibitor resistance patterns in the cerebrospinal fluid. AIDS. 14: 1949–1954. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cysique L, Maruff P, et al, (in press). Antiretroviral therapy in HIV-infection: are neurologically active drugs important?. Arch Neurol
   Google Scholar
• Dore G J, Correll P K, et al, 1999. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 13: 1249–1253. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dore G J, McDonald A, et al, 2003. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 17: 1539–1545. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dunbar N, Perdices M, et al, 1992. Changes in neuropsychological performance of AIDS-related complex patients who progress to AIDS. AIDS. 6: 691–700. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ellis R J, Hsia K, et al, 1997. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neuro cognitively impaired individuals with Acquired Immuno Deficiency Syndrome. Ann Neurol. 42(5)679–688. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ferrando S, Van, Gorp W, et al, 1998. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS. 12: F65–F70. [PUBMED], [INFOTRIEVE], [CROSSREF]
   Web of Science ®Google Scholar
• Goodkin K, Wilkie F L, et al, 2001. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1 associated morbidity and mortality. J Clin Epidemiol. 54: S35–S43. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Grunseit A C, Perdices M, et al, 1994. Neuropsychological function in asymptomatic HIV-1 infection: methodological issues. J Clin Exp Neuropsychol. 16: 898–910. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Heaton R, Grant I, et al, 1995. The HNRC 500-Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1: 231–251. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hirschel B, Opravil M. 1999. The year in review: antiretroviral treatment. AIDS. 13: S177–S187. [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Howell D C. 2002; Statistical methods for psychology, 5th ed., Duxbury, Thomson Learning
   Google Scholar
• Lezak M D. 1995; Neuropsychological assessment, 4th ed., New York, Oxford University Press
   Google Scholar
• Lovibond S H, Lovibond P F. 1995; Manual for the Depression Anxiety Stress Scales, 2nd. Ed., Sydney, Psychology Foundation
   Google Scholar
• McArthur J C, Hoover D R, et al, 1993. Dementia in AIDS patients: incidence and risk factors. Neurology. 43: 2245–2252. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McArthur J C, McClernon D R, et al, 2002. Viral load markers and neurological status: a report from the North-East Dementia Cohort. J NeuroVirol. 8(Suppl 1) Abstract 19.
   Google Scholar
• McArthur J C, McDermott M P, et al, (In press). Attenuated CNS infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol
   Google Scholar
• Mc, Donald A. 2002; HIV/AIDS, viral hepatitis and sexually transmissible infections, Australia Annual Surveillance Report 2002, National Centre in HIV Epidemiology and Clinical Research University of New South Wales Sydney.
   Google Scholar
• Moore R D, Chaisson R E. 1999. Natural History of HIV infection in the era of combination antiretroviral therapy. AIDS. 13: 1993–1942. [CROSSREF]
   Google Scholar
• Neuenburg J K, Brodt H R, et al, 2002. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 31: 171–177. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Perneger T V. 1998. What's wrong with Bonferroni adjustments. BMJ. 316: 1236–1238. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Radloff L S. 1977. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1: 385–401
   Web of Science ®Google Scholar
• Sacktor N, McDermott M, et al, 2002. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol. 8: 136–142. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sacktor N, Tarwater P M, et al, 2001. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology. 57: 542–544. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Sacktor N C, Bacellar H, et al, 1996. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J NeuroVirol. 2: 404–410. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sacktor N C, Lyles R H, et al, 1999. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Neurology. 52: 1640–1647. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Smith A.. 1982; Symbol Digit Modalities Test manual. Los Angeles, Western Psychological Services
   Google Scholar
• Spielberger C D, Gorsuch R L, Lushene R E. 1970; Manual for the State-Trail Anxiety Inventory. Palo Alto, Consulting Clinical Psychologists Press
   Google Scholar
• Suarez S, Baril L, et al, 2001. Outcome of patients with HIV-1 related cognitive impairment on highly active antiretroviral therapy. AIDS. 15: 192–200. [CROSSREF]
   Google Scholar
• Tozzi V, Balestra P, et al, 1999. Positive and sustained effects of highly active antiretroviral therapy on HIV-1 associated neurocognitive impairment. AIDS. 13: 1889–1897. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, et al, 2001. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr. 28: 19–27. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Venturi G, Catucci M, et al, 2000. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis. 181: 740–745. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zakzanis K K. 2001. Statistics to tell the truth, the whole truth, and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect sizes analyses for neuropsychological researchers. Arch Clin Neuropsychol. 16: 653–667. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar